|
Market Closed -
TEL AVIV STOCK EXCHANGE
14:44:58 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,054.00 ILa | +0.09% |
|
-1.13% | -3.66% |
| Market Cap | 120M 0 40.25M 34.48M 32.26M 29.53M 55.42M 3.85B 56.15M 381M 149M 1.93B 151M 148M 6.4B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 248M 0 83.08M 71.16M 66.59M 60.95M 114M 7.95B 116M 787M 307M 3.99B 312M 305M 13.21B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.09% | ||
| 1 week | -1.13% | ||
| Current month | -2.95% | ||
| 1 month | -0.09% | ||
| 3 months | -5.98% | ||
| 6 months | -14.17% | ||
| Current year | -3.66% |
| 1 week | 1,032 |  | 1,091 |
| 1 month | 1,032 | | 1,144 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -1.13% | -9.14% | -34.37% | 40.25M | |
| +2.40% | -1.16% | +21.66% | +101.69% | 100B | |
| +0.46% | -2.41% | +51.42% | +163.99% | 53.38B | |
| 0.00% | -2.68% | +1.75% | +279.08% | 23.91B | |
| -2.82% | -2.41% | -15.68% | -14.61% | 8.09B | |
| -6.08% | -5.45% | -38.53% | -23.47% | 7.33B | |
| +0.42% | -0.30% | -15.40% | -23.27% | 6.63B | |
| +0.88% | -3.48% | +4.43% | +19.93% | 6.34B | |
| -0.91% | +1.05% | -4.38% | +17.58% | 5.09B | |
| -2.58% | -2.96% | -9.58% | -4.65% | 3.64B | |
| Average | -0.81% | -1.80% | -1.34% | +48.19% | 21.46B | |
| Weighted average by Cap. | +0.89% | -1.77% | +20.57% | +118.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 108M 92.19M 86.26M 78.96M 148M 10.3B 150M 1.02B 397M 5.17B 404M 395M 17.11B | 301M 0 101M 86.26M 80.71M 73.88M 139M 9.63B 140M 954M 372M 4.84B 378M 370M 16.01B |
| Net income | 6.21M 0 2.08M 1.78M 1.66M 1.52M 2.86M 199M 2.9M 19.66M 7.67M 99.79M 7.8M 7.63M 330M | -18.07M -0 -6.05M -5.18M -4.85M -4.44M -8.33M -579M -8.44M -57.26M -22.33M -291M -22.7M -22.21M -961M |
| Net Debt | 127M 0 42.52M 36.42M 34.08M 31.19M 58.54M 4.07B 59.32M 403M 157M 2.04B 160M 156M 6.76B | 128M 0 42.83M 36.68M 34.33M 31.42M 58.97M 4.1B 59.75M 406M 158M 2.06B 161M 157M 6.81B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | ILA 1,054.00 | +0.09% | 51 |
| 20/08/26 | ILA 1,053.00 | -0.66% | 1,172 |
| 19/08/26 | ILA 1,060.00 | -0.56% | 107 |
| 18/08/26 | ILA 1,066.00 | 0.00% | 2 |
| 17/08/26 | ILA 1,066.00 | 0.00% | 404 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
